Mind Medicine

+$0.0593 (+8.33%) Today
+$0.0069 (+0.89%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mind Medicine and other ETFs, options, and stocks.

About MNMD

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine.

CEO
Robert Barrow
Employees
41
Headquarters
New York, New York
Founded
2019

MNMD Key Statistics

Market cap
325.71M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.84M
High today
$0.7789
Low today
$0.72
Open price
$0.7248
Volume
2.65M
52 Week high
$4.04
52 Week low
$0.701

MNMD Earnings

-$0.09
-$0.06
-$0.03
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.05 per share
Actual
-$0.04 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure